Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
UNITED STATES OF AMERICA et al v. JOHNSON & JOHNSON et al
Case Number:
3:12-cv-07758
Court:
Nature of Suit:
Other Statutes: False Claims Act
Judge:
Firms
Companies
Sectors & Industries:
-
December 21, 2021
Janssen Denied Early Defeat Of HIV Medication FCA Suit
A New Jersey federal judge denied drugmaker Janssen Products LP's bid to beat a 9-year-old False Claims Act suit without a trial, ruling Tuesday that there are still many open questions in the suit over whether Janssen benefited from off-label marketing of two medications that can stave off HIV.
-
April 08, 2019
Janssen Needn't Show Earnings In Off-Label Use Suit
Drugmaker Janssen Products LP doesn't have to turn over documents that show the profits it made by allegedly selling HIV/AIDS medication for off-label uses in violation of federal law, a New Jersey federal court ruled Monday.
-
May 31, 2017
Janssen Can't Escape Bulk Of FCA Suit Over HIV Drug
A New Jersey federal judge ruled Wednesday that Janssen Products LP must face the bulk of claims in a False Claims Act lawsuit alleging the drugmaker unlawfully benefited from promoting off-label uses of HIV/AIDS medication, but said Johnson & Johnson couldn't be held liable simply because it's Janssen's corporate parent.